XML 57 R89.htm IDEA: XBRL DOCUMENT v3.19.2
Reportable Segments - Operating Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jul. 31, 2019
Apr. 30, 2019
Jan. 31, 2019
Oct. 31, 2018
Jul. 31, 2018
Apr. 30, 2018
Jan. 31, 2018
Oct. 31, 2017
Jul. 31, 2019
Jul. 31, 2018
Jul. 31, 2017
Segment Reporting Information [Line Items]                      
Net sales $ 239,476 $ 228,552 $ 224,538 $ 225,589 $ 228,854 $ 217,268 $ 213,034 $ 212,766 $ 918,155 $ 871,922 $ 770,157
Income from operations                 83,519 121,664 110,410
Interest expense, net                 9,505 5,289 4,303
Other income                 (1,305) (1,138) (126)
Income before income taxes                 75,319 117,513 106,233
Identifiable assets 1,070,366       963,708       1,070,366 963,708  
Capital expenditures                 95,438 37,698 27,065
Depreciation and amortization                 42,359 34,830 33,452
Operating Segment                      
Segment Reporting Information [Line Items]                      
Income from operations                 146,119 161,020 142,753
General corporate                      
Segment Reporting Information [Line Items]                      
Income from operations                 62,600 39,356 32,343
Identifiable assets 62,054       88,101       62,054 88,101  
Capital expenditures                 6,677 11,208 5,772
Depreciation and amortization                 1,961 733 518
Medical                      
Segment Reporting Information [Line Items]                      
Net sales                 523,669 473,937 398,773
Medical | Operating Segment                      
Segment Reporting Information [Line Items]                      
Income from operations                 98,356 86,833 73,440
Identifiable assets 532,250       490,702       532,250 490,702  
Capital expenditures                 52,907 18,996 13,816
Depreciation and amortization                 23,033 19,002 18,245
Life Sciences                      
Segment Reporting Information [Line Items]                      
Net sales                 201,022 217,030 196,446
Life Sciences | Operating Segment                      
Segment Reporting Information [Line Items]                      
Income from operations                 20,552 36,803 33,159
Identifiable assets 184,737       151,460       184,737 151,460  
Capital expenditures                 16,408 4,409 3,689
Depreciation and amortization                 7,482 5,628 5,706
Dental                      
Segment Reporting Information [Line Items]                      
Net sales                 161,608 149,360 144,457
Dental | Operating Segment                      
Segment Reporting Information [Line Items]                      
Income from operations                 22,289 30,004 28,000
Identifiable assets 272,309       210,831       272,309 210,831  
Capital expenditures                 16,243 2,441 2,492
Depreciation and amortization                 9,844 8,756 8,556
Dialysis                      
Segment Reporting Information [Line Items]                      
Net sales                 31,856 31,595 30,481
Dialysis | Operating Segment                      
Segment Reporting Information [Line Items]                      
Income from operations                 4,922 7,380 8,154
Identifiable assets $ 19,016       $ 22,614       19,016 22,614  
Capital expenditures                 3,203 644 1,296
Depreciation and amortization                 $ 39 711 $ 427
Restatement Adjustment | Life Sciences                      
Segment Reporting Information [Line Items]                      
Net sales                   5,820  
Income from operations                   1,704  
Restatement Adjustment | Dental                      
Segment Reporting Information [Line Items]                      
Net sales                   (5,820)  
Income from operations                   $ (1,704)